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The study was performed to assess, for the first time, the in vitro anti-diabetic potential of ten Asteraceae
plant extracts to inhibit the activity of digestive enzymes (a-amylase, a-, b-glucosidases and lipase)
responsible for hydrolysis/digestion of sugar and lipids. Prevention of advanced glycation end-products
(AGEs) formation was evaluated in bovine serum albumin/ribose glycation reaction model. The phyto-
chemical profiles and caffeoylquinic acids (CQAs) contents were determined for the methanolic extract of
each plant. Analyzed plant extracts exhibited significant inhibitory activity against key digestive enzymes
linked to type II diabetes and obesity. A strong inhibition was observed for glucosidases and mild activity
towards amylase and lipase (compared to reference compounds). Moreover, some extracts exhibited
potent ability to prevent formation of AGEs, implicated in some diabetic complications. Caffeoylquinic
acids were dominant in all plant extracts and findings demonstrate that these compounds are the most
relevant hypoglycemic and anti-glycation agents. From the obtained results, Argyranthemum pinnatifi-
dum, Helichrysum melaleucum, and Phagnalon lowei are good candidates for further development of
phyto-pharmaceutical preparations as complementary therapy for diabetes and obesity control.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Type II diabetes (T2D) is a chronic metabolic disease charac-
terized by hyperglycemia, due to inefficient insulin secretion (de la
Garza et al., 2013; Orhan et al., 2014). Prolonged hyperglycemia can
induce non-enzymatic glycosylation of proteins, lipids and nucleic
acids that lead to the development of diabetic complications (Bains
and Gugliucci, 2017; Tsuji-Naito et al., 2009). One practical target
for decreasing post-prandial hyperglycemia is to prevent the ab-
sorption of carbohydrates after food intake (Nurul et al., 2013).
Digestive enzymes such as glucosidases, amylase and lipase controlucts; AMG, aminoguanidine;




ntent.the breakdown and absorption of glucose and lipids and their
precursors in the gastrointestinal tract (Chethan et al., 2014).
Several synthetic inhibitors (acarbose, miglitol, voglibose and
orlistat) are currently available and seems to be an effective way to
control T2D and obesity (Podsędek et al., 2014). However, these
pharmaceutical drugs can cause side/adverse effects (abdominal
pain, flatulence, diarrhea, hepatotoxicity) due to the increase of
undigested starch and lipids levels in the colon (de la Garza et al.,
2013; Nurul et al., 2013). As a result, the attention of the scientific
community has been directed towards the search for novel effective
agents isolated from medicinal or edible plants (Chethan et al.,
2014; Orhan et al., 2014). The natural active phytochemicals pre-
sent in some plants (polyphenols, terpenoids, saponins, poly-
saccharides, steroids) can provide an alternative strategy with
relatively lower cost (Arulselvan et al., 2014; El-Abhar and Schaalan,
2014). Moreover, the use plant extracts as a combination therapy
can contribute to reduce the intake of pharmaceutical drugs and,
consequently, reduce side effects (Ranilla et al., 2010).
Within the 165 endemic species of Madeira archipelago, Heli-
chrysum devium Johns., Helichrysum melaleucum Rchb. Ex Holl,
V. Spínola, P.C. Castilho / Phytochemistry 143 (2017) 29e3530Helichrysum obconicum DC., and Helichrysum monizii Lowe (Aster-
aceae) herbs stand out for their use in treatment of respiratory and
gastro-intestinal diseases: (Rivera and Obon, 1995). Other Aster-
aceae species like Andryala glandulosa ssp. varia (Lowe ex DC.) R.
Fern, Artemisia argentea L'Herit and Cyanara cardunculus L. (var.
ferocissima) Lowe have also been applied for other medicinal pur-
poses (Rivera and Obon, 1995). Previous studies developed by our
work group (Gouveia et al., 2013; Gouveia and Castilho, 2012a,
2012b, 2011a, 2011b, 2010, 2009) have shown that caffeoylquinic
acids (CQAs) are the dominant polyphenols in these species. This
class of compounds is particularly abundant in Asteraceae plants
(Gouveia and Castilho, 2012c) and is reported to possess beneficial
hypoglycemic, hypolipidemic and hepatoprotective properties
(Bahadoran et al., 2013; Hanhineva et al., 2010; Meng et al., 2013;
Narita et al., 2012).
Although the antioxidant activities of some of these plants have
been published (Gouveia et al., 2013; Gouveia and Castilho, 2012b,
2011b) there is no information about their potential on the man-
agement of diabetes and obesity. Thus, the focus of this study was
to evaluate their inhibitory activities on key digestive enzymes (a-
amylase, a-, b-glucosidases and lipase) and on the formation of
advanced glycation end-products (AGEs) using in vitro models.
Moreover, this is the first report on the phytochemical composition,
hypoglycemic and anti-glycation effects of other three Asteraceae
species (Calendula maderensis DC, Argyranthemum pinnatifidum
Lowe var. pinnatifidum and Phagnalon lowei DC). These new data
may stimulate cultivation and induce utilization of targeted plant
species towards the development of phytho-pharmaceuticals.
2. Results and discussion
The phytochemical profiles of A. pinnatifidum, C. maderensis and
P. lowei are here described for the first time. These profiles are
shown in supplementary material (Supplementary Fig. 1 and
Table 1). The phenolic composition of remaining samples has been
established previously by our work group (Gouveia et al., 2013;
Gouveia and Castilho, 2012a, 2012b, 2011a, 2011b, 2010, 2009).
Since CQAs contributed to the major components of analyzed plant
species (Fig. 1), their quantification was further determined.
2.1. Quantification of caffeoylquinic acids
The content of CQAs varied significantly between targeted
species (Table 2). P. lowei showed the highest total amount of CQAs,
followed by H. melaleucum, A. pinnatifidum and H. monizii;
A. glandulosa presented the lowest concentrations (p < 0.05).
Additionally, differences (p < 0.05) were found for H. melaleucum
collected at different seasons/areas. It is known that a number of
factors can affect the phenolic composition of plants (environ-
mental and soil conditions, harvest time, genetic variability) (Dalar
and Konczak, 2014; Podsędek et al., 2014). 1,5-O-diCQA and 5-O-
CQA were found to be major compounds in analyzed plants
(Table 2). The first component was dominant in most Helichrysum
species, A. pinnatifidum (flowers) and P. lowei. 5-O-CQAwas present
in highest amounts on A. argentea, A. pinnatifidum (leaves) and
C. maderensis. For H. obconicum and A. glandulosa samples, 3,5-O-
diCQA was the dominant compound, while for C. cardunculus was
4,5-diCQA. 1,3-O-diCQA and 3,4-O-diCQAwere the isomers present
in lower amounts. 3,4,5-O-triCQA was determined only in
H. devium, H. melaleucum and P. lowei (5.29e10.58 mg 100 g1 DP).
2.2. In vitro anti-diabetic assays
Inhibition of digestive enzymes activity by polyphenols is a
reasonable approach to control hyperglycaemia and calorie intakein T2D patients, through reduction of sugar and fatty acids ab-
sorption from the intestine (Chethan et al., 2014; Podsędek et al.,
2014). To this end, medicinal herb extracts have been as comple-
mentary therapy of diabetic and obesity complications (Arulselvan
et al., 2014; El-Abhar and Schaalan, 2014).
All analyzed plants showed different effects on the assayed
digestive enzymes, as shown in Table 3: A. pinnatifidum showed the
strongest inhibition of yeast a-glucosidase activity (p < 0.05) and
C. maderensis the lowest. Six out of ten plant extracts showed
higher inhibitory effect than standard anti-diabetic drug acarbose
(<2.06 mg mL1 DE) (Table 3). Leaves of A. pinnatifidumwere more
effective than 1-deoxynojirimycin (1-DNJ), a known glucosidases
inhibitor isolated from mulberry leaves (Morus spp. L.).
a-Glucosidase isolated from yeast has been widely used for
pharmacological screenings (Yin et al., 2014). However, a-glucosi-
dase from rat closely mimics the human system and, therefore,
provides a better model to validate results (Babu et al., 2004). So, in
this work, both glucosidases were tested to verify and compare any
differences in the enzyme inhibitory action of plants extracts. It was
observed that the IC50 values of analyzed extracts were higher than
in the microbial version of the enzyme (Table 3). A correlation of
0.901 at p < 0.05 was obtained from results of both a-glucosidase
models. By contrast, acarbose and 1-DNJ displayed superior
inhibitory activity on rat a-glucosidase (about 17 and 65 times
higher, respectively). Previous works (Shai et al., 2011; Tadera et al.,
2006) have reported a higher effectiveness of acarbose over
mammalian enzyme than over the yeast counterpart. Interestingly,
the action of the three CQA derivatives on the inhibition of the
activity of both enzymes is of the same order of magnitude and,
although weaker than acarbose, much superior to the extracts.
Overall, this study confirm that inhibition of yeast a-glucosidase
does not translate into comparable inhibition of the mammalian
enzyme. These findings are in agreement with previous works
(Babu et al., 2004; Shai et al., 2011; Tadera et al., 2006) that
observed a decrease on the efficiency of extracts and flavonoids on
rat a-glucosidase when compared to the microbial equivalent. The
discrepancy is due to the structural differences of the catalytic re-
gions responsible for molecular recognition in the binding site of
the enzymes (Shai et al., 2011). Hence, most yeast a-glucosidase
inhibitors do not show activity on the mammalian equivalent
(Kimura et al., 2004). a-Glucosidases are widely distributed in
microorganisms, plants and animals and the catalytic region is
known to differ greatly depending on their origin (Oki et al., 1999).
By analysis of the amino acid sequences containing the catalytic
sites, these enzymes are generally classified into two groups: family
I and family II. The first family consists of bacterial, yeast and insect
enzymes and are composed of four catalytic regions; while family II
(mold, plants and mammalian) have two catalytic sites responsible
for the enzyme reaction (Kimura et al., 2004). These differences
justify the divergent values obtained in this work (Table 3). Our
findings support the use of mammalian a-glucosidase as a prefer-
able model to investigate new antihyperglycemic agents. Con-
duritol B epoxide, a known b-glucosidase inhibitor, wasmore active
than A. glandulosa, C. cardunculus and C. maderensis (p < 0.05) but
all the other plant extracts performed better than the reference.
P. lowei, H. obconicum, H. melaleucum and A. pinnatifidum showed
the highest b-glucosidase inhibition (p < 0.05), while C. maderensis
was the less active species. 1-DNJ showed the best inhibitory ac-
tivity among tested samples (p < 0.05). Apart from H. obconicum,
these very active species are also those with the highest contents in
CQAs, mainly 5-O-CQA and 1,5-di-O-CQA, which indicates these
two compounds as the most relevant to the observed activity.
However, H. obconicum is unique on having 3,5-di-O-CQA as main
component on a relatively low CQA contents. This points out to a
very high activity of this molecule, in fact, when individually
Fig. 1. HPLC-DAD chromatograms (320 nm) from A. pinnatifidum (AP), C. maderensis (CM) and P. lowei (PL) methanolic extracts. Peak identification: (23) 5-O-CQA; (43) 1,3-O-diCQA;
(95) 3,4-O-diCQA; (100) 1,5-O-diCQA; (101) 3,5-O-diCQA; (113) 4,5-O-diCQA; and (155) 3,4,5-O-triCQA.
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derivatives (p < 0.05) (Table 3).
These experiments have shown that tested plants have a mod-
erate a-amylase inhibitory capacity (Table 3). All samples presented
higher IC50 values than acarbose (0.02 mg mL1) (p < 0.05).
A. pinnatifidum, A. argentea, H. devium and H. melaleucumwere the
most effective inhibitors of this enzyme (< 2 mg mL1 DE), while
C. maderensis and C. cardunculus showed the highest IC50 values.
For the lipase assay (Table 3), plant extracts showed weaker
inhibition effect than commercial drug orlistat (p < 0.05). P. lowei
showed the stronger inhibition, while C. maderensis showed the
lowest effect (p < 0.05). Again, CQA derivatives presented activities
similar to the commercially available drug.
Similar plants have been analyzed for their inhibitory activity by
other authors in previous works: marigold (Calendula officinalis)
extracts were less effective towards a-amylase and lipase than
acarbose (Olennikov and Kashchenko, 2014) and orlistat
(Hernandez-Saavedra et al., 2016), respectively. Artemisia apiaceae
and Artemisia cappilaris exhibited higher inhibition capacity than
acarbose for yeast a-glucosidase assay (Nurul et al., 2013), while
Artemisia vulgaris was a more relevant inhibitor of yeast a-gluco-
sidase than of a-amylase (Chethan et al., 2014). Helichrysum itali-
cum showed higher inhibitory activities against yeast a-glucosidase
and a-amylase (0.19 and 0.83 mg mL1 DE, respectively) (de la
Garza et al., 2013) than tested extracts. It should be observed that
high a-glucosidase but lower a-amylase inhibitory activity is rec-
ommended for an efficient drug, in order to prevent bacterial
fermentation of excessive undigested carbohydrates in the colon,
which results in undesirable side-effects (flatulence and diarrhea)
(de la Garza et al., 2013; Nurul et al., 2013).
Globe artichoke (Cynara scolymus) had a weak inhibitory effects
at 100 mg mL1 (about 20%) towards a-glucosidase from Bacillus
stearothermophilus and lipase when compared to positive controls
(acarbose and orlistat, respectively) (Villiger et al., 2015). Similar topresent work, common chicory (Cichorium intybus) and sowthistle
(Sonchus subsp. asper and oleraceus) are reported to act as strong a-
glucosidase inhibitors, but possess a weak a-amylase and lipase
inhibition activities (Conforti et al., 2012; Dalar and Konczak, 2014).
Higher inhibitions were found for H. graveolens and H. plicatum ssp.
plicatum (IC50 ¼ 0.71 and 0.86 mg mL1, respectively) towards a-
glucosidase from B. stearothermophilus (Orhan et al., 2014).
Plants/herbs from Asteraceae family have been used in folk
medicine for a long time (Chethan et al., 2014; Hernandez-Saavedra
et al., 2016; Nurul et al., 2013; Olennikov and Kashchenko, 2014;
Villiger et al., 2015). Their beneficial properties are mainly attrib-
uted to their high CQAs contents. We initially observed that
analyzed species with the highest CQAs content presented showed
the most efficient inhibitory activities. Considering that 5-O-CQA,
1,5 and 3,5-di-O-CQAs were found in high amounts in the analyzed
extracts, the inhibitory potential of these compounds were further
evaluated in detail. 5-O-CQA (the main compound in 6 of the 10
analyzed extracts) was found to be an effective inhibitor of targeted
enzymes (Table 3), with lower IC50 values than positive controls in
yeast a-glucosidase, b-glucosidase and lipase assays (p < 0.05). In
case of rat a-glucosidase, its potency was only inferior to 1-DNJ and
acarbose. Additionally, it was more effective than analyzed extracts
and other CQAs towards a-amylase (Table 3). In agreement, extracts
with the highest 5-O-CQA contents exhibited stronger inhibitory
activities (Tables 2 and 3). In case of di-CQA isomers, their potent
inhibitory activity towards digestive enzymes was also noted
(Table 3).
Previously (Bahadoran et al., 2013; Hanhineva et al., 2010; Meng
et al., 2013; Narita et al., 2012), CQAs have been reported as potent
inhibitors of digestive enzymes. 5-O-CQA action is known to
resembled that of commercially available drugs such as acarbose,
miglitol, and voglibose, which are widely used in control of
hyperglycaemia (Meng et al., 2013). In the present study, 5-O-CQA
was more effective than acarbose towards a-glucosidase (Table 3).
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suggesting binding to, or interaction with, other sites than the
recognized active site of the enzyme (Ishikawa et al., 2007). The
esterification of caffeic acid with quinic acid seems to increase its
ability to inhibit carbohydrate digestive enzymes (Chen et al., 2014;
Funke and Melzig, 2005; Ishikawa et al., 2007; Narita and Inouye,
2009). Other studies (Meng et al., 2013; Narita et al., 2012; Narita
and Inouye, 2009; Worsztynowicz et al., 2014) have also reported
the strong in vitro inhibitory effect of CQAs and its derivatives on a-
amylase and pancreatic lipase activities. In this sense, 5-O-CQA can
be considered as one of the main active anti-hyperglycemic agents
of targeted plants; Nevertheless, other polyphenols present in the
extracts, namely other CQAs derivatives, might also contribute for
the obtained results. The present data (Table 3) demonstrate that 5-
O-CQA, 1,5- and 3,5-di-O-CQAs are the major hypoglycemic agents
present in extracts of analyzed plants.
Glycation is a non-enzymatic reaction between the carbonyl
group of reducing sugars and a free amino group of proteins that
result to the formation of AGEs (Bains and Gugliucci, 2017;
Gugliucci et al., 2009). Formation of AGEs induced by hyperglyce-
mia is involved in the pathogenesis of atherosclerosis, nephropa-
thies and retinopathy (Li et al., 2014; Sero et al., 2013). As such,
inhibition of AGE formation represents another therapeutic target
for the prevention and treatment of diabetic complications
(Chinchansure et al., 2015). The analyzed plant extracts showed
good in vitro inhibitory potential to glycation of BSA (Table 3).
Leaves of A. pinnafitidum and P. lowei and H. melaleucum showed
the highest anti-glycation activities ( 1.92 mgmL1 DE) (p < 0.05).
All tested samples showed a lower IC50 values than AMG, an
investigational AGEs inhibitor drug. The same behavior was docu-
mented before for Chrysanthemum species (Asteraceae) extracts
(Tsuji-Naito et al., 2009). This is might be due to the fact that AMG is
not effective in the early stage of protein glycation since it acts as a
carbonyl scavenger (Chinchansure et al., 2015). Quercetin displayed
the best inhibitory activity among tested samples (p < 0.05). This is
in agreement with previous publications (Chinchansure et al., 2015;
Li et al., 2014; Sero et al., 2013) that report quercetin and com-
pounds with quercetin-like structure (flavonols) more effective
than other flavonoids and AMG towards formation of AGEs.
5-O-CQA revealed a strong inhibitory effect, superior to AMG
and comparable to quercetin (p < 0.05). 1,5- and 3,5-di-O-CQAs
were also active compounds (Table 3). Based on these findings,
CQAs may be considered the main factors responsible for the pre-
vention of AGEs formation in the analyzed plant extracts (Table 3).
It is know that, 5-O-CQA possess potent anti-glycation effects
(Chinchansure et al., 2015). In fact, caffeic acid and 5-O-CQA iso-
lated from I. paraguariensis are the main inhibitors of AGES for-
mation and have also shown higher anti-glycation activities than
that of AMG (Bains and Gugliucci, 2017; Gugliucci et al., 2009). In
another study, extracts of C. morifolium exhibited comparable anti-Table 1
Information on botanical name, morphological parts and collection area of targeted Aste
Botanical name Common names Morpholo
A. glandulosa ssp. var. (L. ex DC.) R. Fern Bofe de burro Leaves
A. pinnatifidum L. (var. pinnatifidum) Estreleira; Malmequer Leaves; F
A. argentea L'Herit Losna Leaves; F
C. maderensis DC. Vaqueira Leaves; F
C. cardunculus L. (var. ferocíssima) Cardo; Pencas Total aeri
H. devium Johns. Perpetua Leaves; F
H. melaleucum Rchb. Ex Holl Perpetua branca Leaves; F
Leaves
H. monizii L. e Total aeri
H. obconicum DC. Aipo branco; Murri~ao Leaves
P. lowei DC. Erva do Iscas Leavesglycation activity to A. pinnatifidum and P. lowei
(IC50 ¼ 1.3 mg mL1), while C. indicum showed lower effects
(IC50 ¼ 10.1 mg mL1) (Tsuji-Naito et al., 2009). Again, CQAs are the
main active principles of above plants against glycation of BSA.
These data support other beneficial effects of targeted extracts in
the control of T2D, besides lowering hyperglycemia throughout
inhibition of digestive enzymes.
3. Experimental
3.1. Chemicals and reagents
All reagents and standards were of analytical reagent (AR) grade
unless stated otherwise. Methanol (99.9%) was obtained from Fluka
(Lisbon, Portugal). Sodium carbonate (100%), a-glucosidase from
Saccharomyces cerevisiae (type I), intestinal acetone powder from
rat source of a-glucosidase, b-glucosidase from almonds, a-amylase
from porcine pancreas (type VI-B), lipase (type II; from porcine
pancreas), p-nitrophenyl-a-D-glucopyranoside (a-pNPG), p-nitro-
phenyl-b-D-glucopyranoside (b-pNPG), p-nitrophenyl butyrate
(pNPB), bovine serum albumin (BSA,  98%), D-(-)-ribose (99%),
aminoguanidine hydrochloride (AMG, 98%), conduritol B epoxide
(95%), acarbose, orlistat and formic acid (98%) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). 5-O-cafeoylquinic acid
(>95%), 1,5-; 1,3-; 3,4-; 4,5-di-O-caffeoylquinic acids (>98%), 3,4,5-
O-tricaffeoylquinic acid (>98%) and 1-deoxynojirimycin (95e99%;
1-DNJ) were purchased from Biopurify Phytochemicals LTD
(Chengdu, China). Ethylenediaminetetraacetic acid (EDTA, >99%)
and sodium azide (>99%) were obtained from Merck (Darmstadt,
Germany). LCeMS grade acetonitrile (CH3CN, 99%) (LabScan;
Dublin, Ireland) and ultrapure (UP) water (Milli-Q Waters purifi-
cation system; Millipore; Milford, MA, USA) were used for the
HPLC-MS analyses.
3.2. Sample preparation and extraction of phenolic compounds
Plant material was collected in different locations of Madeira
archipelago between May and December 2014 and identified by
specialists from Madeira Botanical Garden (Funchal, Madeira).
Vouchers were deposited at Madeira Botanical Garden Herbarium
(for a more detailed description see Table 1). Leaves were separated
from flowers, lyophilized to dryness (Alpha 1e2 LD plus freeze
dryer, CHRIST), ground to powder in a mechanic grinder, and stored
at 20 C. Phenolic extraction followed a previous procedure
(Gouveia and Castilho, 2011b). The resulting extracts were stored at
4 C until further analysis.
3.3. HPLC analysis
The HPLC-ESI-MSn analysis was performed on a Dionex ultimateraceae plant species endemic from Madeira archipelago.
gical parts Collection area Voucher Number
Pico Grande, Madeira Island MADJ13175
lowers Ribeira das Cales, Madeira Island MADJ13185
lowers Pico Branco, Porto Santo Island MADJ13164
lowers S~ao Jorge, Madeira Island MADJ13165
al parts Ponta de S~ao Lourenço, Madeira Island MADJ13162
lowers Ponta de S~ao Lourenço, Madeira Island MADJ13180
lowers S~ao Vicente, Madeira Island
Ilheu de Cima, Porto Santo Island
MADJ13177
MADJ13192
al parts Funchal, Madeira Island MADJ13178
Ponta de S~ao Lourenço, Madeira Island MADJ13179
Ilheu de Cima, Porto Santo Island MADJ13186
Table 2
Contents of caffeoylquinic acids (CQAs) in targeted Asteraceae species endemic from Madeira archipelago (mg 100 g1 of dry plant).
Compound 5-CQA 1,3-diCQA 3,4-diCQA 1,5-diCQA 3,5-diCQA 4,5-diCQA 3,4,5-triCQA Total amount
A. argentea Leavesb 358.62 ± 2.09 4.15 ± 0.07 a 275.00 ± 1.04 a 32.90 ± 0.41 N.D. 670.67 ± 3.28h
Flowers 359.51 ± 1.98 32.48 ± 0.32 a 269.68 ± 0.99 a 13.69 ± 0.09 N.D. 675.36 ± 4.97h
Leavesb 495.50 ± 3.32 9.81 ± 0.06 a 323.74 ± 1.06 a 22.11 ± 1.01 N.D. 851.16 ± 3.77j
A. glandulosa Leaves¥ 22.40 ± 0.21 N.D. N.D. N.D. 50.69 ± 1.1 3.81 ± 0.03 N.D. 85.90 ± 1.3a
A. pinnatifidum Leaves 838.48 ± 2.11 0.84 ± 0.06 8.65 ± 0.13 430.22 ± 1.11 14.38 ± 0.16 8.77 ± 0.07 N.D. 1301.34 ± 2.14n
Flowers 214.16 ± 0.89 0.40 ± 0.01 4.65 ± 0.07 636.99 ± 2.50 4.80 ± 0.06 6.17 ± 0.05 N.D. 867.17 ± 0.89k
C. ferocissima Total aerial parts 77.20 ± 0.54 0.80 ± 0.03 N.D. 8.4 ± 0.09 65.80 ± 0.27 89.24 ± 0.47 N.D. 241.44 ± 1.07e
C. maderensis Leaves 191.51 ± 0.77 a a 2.03 ± 0.01 a 1.01 ± 0.01 N.D. 194.55 ± 1.07c
Flowers 180.49 ± 0.64 a a 32.23 ± 0.54 a 2.02 ± 0.02 N.D. 214.74 ± 1.32d
H. devium LeavesF 35.19 ± 0.06 2.73 ± 0.05 a 125.4 ± 0.03 0.462 ± 0.02 17.33 ± 0.05 5.29 ± 0.04 186.4 ± 0.71b
FlowersF 129.2 ± 1.20 a 1.89 ± 0.04 197.3 ± 0.39 49.92 ± 0.19 40.58 ± 0.03 a 422.6 ± 1.8f
H. melaleucum LeavesF 345.0 ± 1.20 5.86 ± 0.03 N.D. 915 ± 1.4 30.61 ± 1.6 60.44 ± 0.43 10.58 ± 0.01 1367.9 ± 0.64
FlowersF 114.0 ± 0.47 a N.D. 628.8 ± 0.11 N.D. 43.12 ± 0.11 10.15 ± 0.01 804.03 ± 0.74i
Leavesc 355.99 ± 2.50 33.68 ± 0.49 N.D. 687.86 ± 0.96 29.61 ± 0.97 12.26 ± 0.10 a 1119.40 ± 2.45l
H. monizii Total aerial partsF 375.9 ± 0.53 a 16.5 ± 0.05 441.9 ± 0.58 303.29 ± 0.61 31.67 ± 0.06 a 1169.3 ± 1.8m
H. obconicum LeavesF 52.19 ± 0.73 a 16.99 ± 0.24 83.09 ± 2.9 469.5 ± 0.25 82.53 ± 0.11 a 604.7 ± 1.1g
P. lowei Leaves 575.74 ± 2.72 N.D. 1 1276.32 ± 12.97 20.16 ± 0.34 37.27 ± 0.25 8.45 ± 0.36 1917.94 ± 4.33p
¥(Gouveia et al., 2013) F(Gouveia and Castilho, 2012c).
Means in the same column not sharing the same letter are significantly different at p < 0.05 probability level.
a Compounds present in trace amounts (lower than the LOQ); N.D. e Not detected.
b Samples collected in different time periods (May and December 2014).
c Samples collected in Porto Santo Island.
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binary pump, an autosampler and a column compartment (kept at
30 C) and coupled with a Bruker Esquiremodel 6000 ion trapmass
spectrometer with an ESI source (Bremen, Germany). Analysis was
carried out on a Phenomenex Gemini C18 column (5 mm,
250  3.0 mm i.d.) using the same conditions as previously
(Gouveia and Castilho, 2012c). Extract solutions (5 mg mL1) were
prepared by dissolving the dry extract (DE) in the initial HPLC
mobile phase. After filtration through 0.45 mm PTFE membraneTable 3
In vitro inhibitory activities (IC50) of targeted plant extracts towards digestive enzymes a
Plant Species a-Glucosidase
Yeast Rat
A. argentea Leaves 1.36 ± 0.04i 2.79 ± 0.10g
Flowers 2.01 ± 0.06k 2.90 ± 0.08g
Leavesa 1.49 ± 0.04j 3.42 ± 0.17i
A. glandulosa Leaves 5.60 ± 0.11 8.70 ± 0.42k
A. pinnatifidum Leaves 0.57 ± 0.03b 2.39 ± 0.14g
Flowers 0.81 ± 0.02d 2.77 ± 0.11g
C. cardunculus Total aerial parts 4.19 ± 0.15n 9.11 ± 0.34l
C. maderensis Leaves 5.29 ± 0.12 10.67 ± 0.19m
Flowers 6.23 ± 0.10 N.D.
H. devium Leaves 1.44 ± 0.03j 4.00 ± 0.18j
Flowers 2.13 ± 0.04l 3.46 ± 0.13i
H. melaleucum Leaves 0.99 ± 0.03f 3.59 ± 0.11i
Flowers 1.25 ± 0.04h 2.72 ± 0.08g
Leavesb 1.13 ± 0.01g 3.07 ± 0.07h
H. monizii Total aerial parts 2.76 ± 0.05m N.D.
H. obconicum Leaves 1.35 ± 0.02i 3.30 ± 0.08i
P. lowei Leaves 0.90 ± 0.03e 2.10 ± 0.11f
5-O-CQA e 0.36 ± 0.02b 0.27 ± 0.02c
1,5-O-DiCQA 0.39 ± 0.03b 0.35 ± 0.02d
3,5-O-DiCQA 0.30 ± 0.02a 0.44 ± 0.03e
Acarbose e 2.06 ± 0.04k 0.12 ± 0.01b
1-Deoxynojrimycin e 0.65 ± 0.02c 0.01 ± 0.01a
Conduritol B epoxide e e e
Orlistat e e e
Aminoguanidine e e e
Quercetin e e e
N.D.: not determined (sample was scarce).
Means in the same column not sharing the same letter are significantly different at p <
a Leaves collected in different time periods (May and December 2014).
b Leaves collected in Porto Santo.filters, 5 mL was injected.3.4. Quantification of caffeoylquinic acids (CQAs)
For the quantitative analysis, a previously validated HPLC-PDA
method was applied (Gouveia and Castilho, 2012c). Identification
and quantification were performed by comparison with standards:
5-CQA, 1,3-; 3,4-; 1,5-; 3,5-, 4,5-O-diCQA and 3,4,5-O-triCQA. Six
concentrations were used for each calibration curve (R2  0.9991)nd BSA glycation.
b-glucosidase a-Amylase Lipase BSA-glycation
3.83 ± 0.10g 1.92 ± 0.04ef 3.85 ± 0.05ef 1.83 ± 0.10f
4.38 ± 0.14i 2.48 ± 0.04h 4.69 ± 0.2gh 2.38 ± 0.19gh
3.96 ± 0.18gh 1.81 ± 0.03de 3.67 ± 0.08e 2.16 ± 0.08g
11.07 ± 0.22m 7.34 ± 0.10j 6.39 ± 0.08j 5.51 ± 0.10l
3.07 ± 0.10f 1.55 ± 0.04c 3.31 ± 0.09d 1.22 ± 0.03d
3.25 ± 0.17f 2.18 ± 0.05g 4.31 ± 0.11g 1.66 ± 0.09ef
9.40 ± 0.12l 9.09 ± 0.11l 7.52 ± 0.13k 4.26 ± 0.27j
11.87 ± 0.11n 8.57 ± 0.10k 8.89 ± 0.16l 6.92 ± 0.18l
12.57 ± 0.30 8.91 ± 0.09l 9.55 ± 0.11m 7.45 ± 0.43m
4.47 ± 0.07i 1.85 ± 0.06de 4.11 ± 0.06fg 2.24 ± 0.14hi
5.17 ± 0.07j 2.39 ± 0.03h 5.17 ± 0.15i 2.84 ± 0.20i
3.18 ± 0.16f 1.71 ± 0.02cd 4.09 ± 0.05fg 1.72 ± 0.10f
4.32 ± 0.09hi 2.15 ± 0.05g 4.95 ± 0.04hi 2.36 ± 0.13gh
2.91 ± 0.11ef 1.92 ± 0.09ef 3.89 ± 0.06ef 1.52 ± 0.09de
N.D. 4.29 ± 0.11i N.D. N.D.
2.51 ± 0.08de 2.48 ± 0.05h 4.37 ± 0.11g 2.49 ± 0.07h
2.33 ± 0.06d 2.07 ± 0.04fg 3.05 ± 0.07d 1.49 ± 0.08e
0.39 ± 0.01b 1.20 ± 0.04b 0.31 ± 0.01a 0.20 ± 0.01b
0.37 ± 0.02b 1.69 ± 0.11cd 0.61 ± 0.04c 0.27 ± 0.02c
0.28 ± 0.02a 2.69 ± 0.20h 0.50 ± 0.03b 0.31 ± 0.02c
e 0.02 ± 0.001a e e
0.45 ± 0.02c e e e
8.94 ± 0.19k e e e
e e 0.47 ± 0.02b e
e e e 9.56 ± 0.36n
e e e 0.11 ± 0.01a
0.05 probability level.
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(>96.24%) for all standard compounds. The amount of each com-
pound was expressed as mg per 100 g of dry plant (DP).
3.5. In vitro enzyme and glycation inhibition assays
a-Glucosidases (from yeast and rat) and a-amylase inhibition
assays were carried out as described previously (Podsędek et al.,
2014; Spínola et al., 2016). The assay for b-glucosidase was con-
ducted based on a-glucosidase assay. Lipase assay was adapted
from a previous report (Kim et al., 2010): 40 mL of extract solution
(serial dilutions) was mixed with 20 mL of substrate solution
(10 mM of p-NPB) and 40 mL of enzyme (2.5 mg mL1 in 0.1 M
phosphate buffer, pH 8.0). After incubation (20 min; 37 C) absor-
bance was read at 405.
Non-enzymatic glycation of BSAwasmeasuredwith adaptations
from a published protocol (Sero et al., 2013): 50 mL of BSA solution
(10 mg mL1), 80 mL of 0.1 M phosphate buffer (containing 3 mM
sodium azide, pH 7.4), 50 mL of ribose solution (0.5 M) and 20 mL of
sample (serial dilutions) were added to each plate. Plates were
incubated for 24 h at 37 C and analyzed at an excitation wave-
length of 355 nm and emission wavelength of 460 nm. All assays
were conducted in a microtiter reader (Victor3, Perkin-Elmer).
Acarbose, orlistat, conduritol B epoxide, 1-DNJ, quercetin and
AMG were used as positive controls and the IC50 values (mg mL1)
were determined from the least-squares regression line of the
logarithmic concentrations plotted against percentage inhibition.
3.6. Statistical analysis
The mean values were calculated based on at least three inde-
pendent replicates (n ¼ 3) and results are presented as
means ± standard deviations. Statistical analysis was carried out
using one-way analysis of variance (ANOVA) followed by Tukey's
post hoc test using SPSS for Windows, IBM SPSS Statistics 20 (SPSS,
Inc., USA) to assess differences between samples. A value of p < 0.05
was considered statistically significant.
4. Conclusion
A. pinnatifidum, H. melaleucum, and P. lowei exhibited the high-
est inhibitions of key digestive enzymes, suggesting their potential
application on regulating glucose and lipids digestion. Targeted
plants showed also effective anti-glycation activities, demon-
strating another efficient role in delay or prevention of diabetic
complications. Caffeoylquinic acids, in particular 5-O-CQA, 1,5- and
3,5-di-O-CQA contribute as the most active principles for the re-
ported in vitro anti-diabetic activities. Nevertheless, the involve-
ment of other compounds, namely other diCQAs, cannot be ruled
out since synergistic effects could potentiate or reduce the inhibi-
tory activities. As a follow-up investigation, we intent to isolate and
study their individual biological properties as well. Additional
in vivo experiments are also required to confirm the biological
relevance of analyzed extracts. Overall, the obtained data are
helpful for further research and development of these plants in the
field of pharmaceutical industries.
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